According to the latest analysis by Future Market Insights (FMI), the global orphan drugs market is transitioning toward advanced biologics, gene therapies, and precision medicine solutions that address previously untreatable rare diseases. The market is projected to grow from USD 207.11 billion in 2026 to USD 324.72 billion by 2036, expanding at a CAGR of 4.60%. The market is expected to...